The quantification of markers of breast cancer in healthy people (26 people for CA 15-3 and 28 people for CEA) by IRMA has shown that the serum concentration of CA15-3 and CEA was 19.12+/- 15.44 u/ml and 4.19 +/- 2.35 ng/ml, respectively. The medium (4.48), mininum (0.00) and maxinum (8.37) ng/ml. These results can be used to compared with markers in patients with breast cancer. There was no difference of these between men and women.
Breast Neoplasms ; breast

The quantitative analysis of the concentration of serum calcitonin was carried out in 29 normal people with ages of 18-50. The results: this is a method with the high confidence; the average concentration of serum calcitonin is 5,74 Pg/ml; the minimal concentration at 0,00 commonly found, the maximal concentration is 22,6 Pg/ml; the distribution was not same as the rule of Gauss so the medial figure was 4,98pg/ml as preparesentative; there is no different of this concentration between male and female.
calcitonin ; serum

Serum levels of tumor maker CA 19-9 were quantified in healthy young and middle adults, including both genders. Participants had to have no sign of tumor or inflammatory diseases. Technically, level of CA 19-9 as quantifying by IRMA kid of CISbio International was reliable with%CV ranged from 0.1 to 5.4. Average value of CA 19-9 is 17.11+/-11.06. Level in high area was no more than 35.7 U/mL. Upper and lower marginal areas were 26.61 U/mL and 5.68 U/mL, respectively. There was no significant difference between two genders
Immunoradiometric Assay ; Serum

The quantification of CA 72-4 and CA 19-9 in normal people and patients with the peptic cancer was analysed and evalutated in the clinical application. The conentration of CA 72-4 and 19-9 in the normal people (disease free, tumor and infection free) and patients with the pepsic cancer (diagnosed by pathological anatomy and cytology) were quantified an compared.
Immunoradiometric Assay ; Peptic Ulcer ; neoplasms

A study was carried out to apply the IRMA to quantity the CA15-3 in the normal person and CA15-3 and CEA in the patients with the breast cancer. The clinical efficacy of CA15-3 and CEA were also evaluated. The subjects were normal people without tumor, chronic diseases, infection, inflamatory, hepatic diseases and the patients with the breast cancer who received the pathological anatomy and cytology.
Breast Neoplasms ; diagnosis ; Immunoradiometric Assay ; neoplasms ; breast

The quantitative analysis of the concentration tumor marker CA15-3 by the immunoradioactive method in the serum of 26 normal persons without the tumor, hepatic diseases and chronic diseases ages of 18-50 has shown that this is method with high accuracy. The radioactive activity is direct proportional with the concentration of CA 15-3; The concentration of CA 15-3 in the normal people is 19,12+/-15,54 u/ml in which 90% persons have concentration under 30% u/ml. The concentration of CA 15-3 is most common in 4,71 u/ml.
Tumor Markers, Biological ; Chronic Disease

Subjects: Normal people without the benign or malignant tumor; standard sample of CA72-4 with concentrations: 0,3; 25; 50 100 u/ml. The results have shown that the standard chart has relatively same as theory; the change factor CV had value within allowed limit in the range of low concentration of CA 72-4 was 4,05+/- 3,06U/ml. The medium value was 4,92 u/ml. The normal range is from 0 to 9 u/ml. There is insignificant different between women and men.
Neoplasms ; Immunoradiometric Assay ; Tumor Markers, Biological

The quantification of markers of gastric tumors in healthy people by IRMA has shown that the serum concentrations of CA 72-4 and CA 19-9 in 49 healthy people with ages of 18-49 was 4.05 +/- 3.07 u/ml and 17.12 +/- 11.06, respectively. There was no difference of specific these markers between men and women. These results can be used to compare with markers in patients with gastric tumors.
Attention ; Stomach Diseases ; diagnosis ; Stomach Neoplasms ; neoplasms

Participants were 28 healthy people involved in genders, included smokers and non-smokers with age ranged from 18 to 50 years. Standard curve was established using 6 prepared sample kits of manufacturer with levels of 0, 4, 20, 80, 140 and 200ng/ml. The findings suggested that for technical standard, CEA quantification with IRMA using kits of France-based CIS Bio International was reliable, quality of kits and qualification skill is good. Average level of CEA maker in 28 subjects above is 4.19+/-2.35ng/ml with mean-point of 4.48, ranged from 0.00 to 8.37ng/ml. The most common level is 6.37ng/ml. Upper-marginal level is 2.59ng/ml and under-marginal level is 3.36ng/ml. There was insignificant difference between male and female.
Administrative Personnel ; Carcinoembryonic Antigen ; Immunoradiometric Assay ; neoplasms

The concentration of TSH - receptor autoantibodies (TRAB) in human serum determined. The results of 30 samples of non-Gravis' disease and 30 samples Gravis' disease were as following: Mean of normal: 1.4+/-0.6U/L, mean of abnormal: 182.1+/-193.6U/l. Sensitivity of method: 90%. Specificity of method: 96%. Stability of method: 93%. Accuracy of method: 91%.
Hyperthyroidism ; diagnosis ; Thyrotropin